Biotricity, Inc. (BTCY) Stock
Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Biotricity, Inc.
Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States. The company's efforts are dedicated to supplying remote monitoring capabilities to the medical, healthcare, and individual consumer markets, encompassing both diagnostic tools and ongoing management support for chronic and lifestyle-related conditions. Among its key offerings are the Bioflux mobile cardiac telemetry solution, an integrated ECG device, alongside specialized ECG analysis software designed to process and synthesize patient heart rhythm data, complemented by various software components.
Biotricity, Inc. is headquartered in US.
Biotricity, Inc. (BTCY) stock trades at $0.10 with a market capitalization of $2.74M. The stock is valued at a price-to-earnings (P/E) ratio of -0.89, price-to-book of -0.09, price-to-sales of 0.17. Over the past 52 weeks the stock has ranged between $0.09 and $0.75, and currently trades 86.7% below its 52-week high.
On profitability, Biotricity, Inc. generates a return on equity (ROE) of 7.52%, return on capital employed of -5.51%, an operating margin of 10.57%, a net profit margin of -15.03%.
Official website: www.biotricity.com